...
首页> 外文期刊>Implementation Science >Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial
【24h】

Systems analysis and improvement approach to optimize the hypertension diagnosis and care cascade for PLHIV individuals (SAIA-HTN): a hybrid type III cluster randomized trial

机译:优化PlHIV患者的高血压诊断和护理级联的系统分析和改进方法(SAIA-HTN):杂交类III集群随机试验

获取原文
           

摘要

BACKGROUND:Across sub-Saharan Africa, evidence-based clinical guidelines to screen and manage hypertension exist; however, country level application is low due to lack of service readiness, uneven health worker motivation, weak accountability of health worker performance, and poor integration of hypertension screening and management with chronic care services. The systems analysis and improvement approach (SAIA) is an evidence-based implementation strategy that combines systems engineering tools into a five-step, facility-level package to improve understanding of gaps (cascade analysis), guide identification and prioritization of low-cost workflow modifications (process mapping), and iteratively test and redesign these modifications (continuous quality improvement). As hypertension screening and management are integrated into chronic care services in sub-Saharan Africa, an opportunity exists to test whether SAIA interventions shown to be effective in improving efficiency and coverage of HIV services can be effective when applied to the non-communicable disease services that leverage the same platform. We hypothesize that SAIA-hypertension (SAIA-HTN) will be effective as an adaptable, scalable model for broad implementation.METHODS:We will deploy a hybrid type III cluster randomized trial to evaluate the impact of SAIA-HTN on hypertension management in eight intervention and eight control facilities in central Mozambique. Effectiveness outcomes include hypertension cascade flow measures (screening, diagnosis, management, control), as well as hypertension and HIV clinical outcomes among people living with HIV. Cost-effectiveness will be estimated as the incremental costs per additional patient passing through the hypertension cascade steps and the cost per additional disability-adjusted life year averted, from the payer perspective (Ministry of Health). SAIA-HTN implementation fidelity will be measured, and the Consolidated Framework for Implementation Research will guide qualitative evaluation of the implementation process in high- and low-performing facilities to identify determinants of intervention success and failure, and define core and adaptable components of the SAIA-HTN intervention. The Organizational Readiness for Implementing Change scale will measure facility-level readiness for adopting SAIA-HTN.DISCUSSION:SAIA packages user-friendly systems engineering tools to guide decision-making by front-line health workers to identify low-cost, contextually appropriate chronic care improvement strategies. By integrating SAIA into routine hypertension screening and management structures, this pragmatic trial is designed to test a model for national scale-up.TRIAL REGISTRATION:ClinicalTrials.gov NCT04088656 (registered 09/13/2019; https://clinicaltrials.gov/ct2/show/NCT04088656).
机译:背景:跨撒哈拉以南非洲,存在基于证据的临床指南和管理高血压;然而,由于缺乏服务准备,卫生工作者的动机不均匀,卫生工作者表现较弱,高血压筛查和管理与慢性护理服务的持久性持久性,卫生工作者的持久性持久性差价低。系统分析和改进方法(SAIA)是一种基于证据的实施策略,将系统工程工具与五步,设施级别的封装相结合,以改善对差距的理解(级联分析),指南识别和低成本工作流程的优先级修改(过程映射),迭代测试和重新设计这些修改(连续质量改进)。随着高血压筛查和管理纳入撒哈拉以南非洲的慢性护理服务,存在有机会测试在应用于非传染性疾病服务时是否有效地测试萨利亚干预措施,可以有效利用相同的平台。我们假设萨亚 - 高血压(SAIA-HTN)作为广泛实施的适应性,可扩展的模型是有效的。方法:我们将部署一个混合型III集群随机试验,以评估SAIA-HTN在八个干预中对高血压管理的影响莫桑比克中部的八种控制设施。有效结果包括高血压级联流量措施(筛查,诊断,管理,控制)以及艾滋病毒患者的人们的高血压和艾滋病毒临床结果。从付款人的角度来看,将估计每次患者通过高血压级联步骤的增量成本,从高血压级联步骤和每次额外残疾寿命年度的成本估算。将测量索亚 - HTN实施保真度,综合实施研究框架将指导在高性能和低性能设施中对实施过程进行定性评估,以确定干预成功和失败的决定因素,以及定义索亚的核心和适应性组件-htn干预。实施变更规模的组织准备将衡量采用Saia-Htn.discussion的设施级别准备:Saia Packages用户友好的系统工程工具,以指导前线卫生工作者的决策,以确定低成本,背景适当的慢性护理改善策略。通过将萨亚融入常规的高血压筛选和管理结构,旨在测试国家尺度尺寸的模型。注册:ClinicalTrials.gov NCT04088656(注册09/13/2019; https://clinicaltrials.gov/ct2 / show / nct04088656)。

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号